Therapeutic compounds for HIV virus infection
US12404262B2 · kind B2 · utility
0Cited by
54References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2022 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Dec 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.